Theressa Creighton is the Senior Clinical Project Manager at ILiAD bringing more than a decade of Clinical Operations experience. Her clinical research career started in academia at the University of Pennsylvania. After moving to Boston, she transitioned to industry at Takeda’s Vaccine Business Unit and most recently managed a first-in-human immune tolerance study in Multiple Sclerosis for a small biotech company. Theressa attended St. John’s College, Annapolis and has a bachelor’s degree from Arizona State University.